|
1
|
Jemal A, Center MM, DeSantis C and Ward
EM: Global patterns of cancer incidence and mortality rates and
trends. Cancer Epidemiol Biomarkers Prev. 19:1893–1907. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dong H, Strome SE, Salomao DR, Tamura H,
Hirano F, Flies DB, Roche PC, Lu J, Zhu G, Tamada K, et al:
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential
mechanism of immune evasion. Nat Med. 8:793–800. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Greenwald RJ, Freeman GJ and Sharpe AH:
The B7 family revisited. Annu Rev Immunol. 23:515–548. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zou W and Chen L: Inhibitory B7-family
molecules in the tumour microenvironment. Nat Rev Immunol.
8:467–477. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Parsa AT, Waldron JS, Panner A, Crane CA,
Parney IF, Barry JJ, Cachola KE, Murray JC, Tihan T, Jensen MC, et
al: Loss of tumor suppressor PTEN function increases B7-H1
expression and immunoresistance in glioma. Nat Med. 13:84–88. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gong AY, Zhou R, Hu G, Li X, Splinter PL,
O'Hara SP, LaRusso NF, Soukup GA, Dong H and Chen XM: MicroRNA-513
regulates B7-H1 translation and is involved in IFN-gamma-induced
B7-H1 expression in cholangiocytes. J Immunol. 182:1325–1333. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang W, Li F, Mao Y, Zhou H, Sun J, Li R,
Liu C, Chen W, Hua D and Zhang X: A miR-570 binding site
polymorphism in the B7-H1 gene is associated with the risk of
gastric adenocarcinoma. Hum Genet. 132:641–648. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hoon DS, Ferris R, Tanaka R, Chong KK,
Alix-Panabières C and Pantel K: Molecular mechanisms of metastasis.
J Surg Oncol. 103:508–517. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kent OA and Mendell JT: A small piece in
the cancer puzzle: microRNAs as tumor suppressors and oncogenes.
Oncogene. 25:6188–6196. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Brennecke J, Stark A, Russell RB and Cohen
SM: Principles of microRNA-target recognition. PLoS Biol.
3:e852005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Brodersen P and Voinnet O: Revisiting the
principles of microRNA target recognition and mode of action. Nat
Rev Mol Cell Biol. 10:141–148. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Makeyev EV and Maniatis T: Multilevel
regulation of gene expression by microRNAs. Science. 319:1789–1790.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Song X, Zhong H, Zhou J, Hu X, Zhou Y, Ye
Y, Lu X, Wang J, Ying B and Wang L: Association between
polymorphisms of microRNA-binding sites in integrin genes and
gastric cancer in Chinese Han population. Tumour Biol.
36:2785–2792. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim M, Chen X, Chin LJ, Paranjape T, Speed
WC, Kidd KK, Zhao H, Weidhaas JB and Slack FJ: Extensive sequence
variation in the 3′ untranslated region of the KRAS gene in lung
and ovarian cancer cases. Cell Cycle. 13:1030–1040. 2014.Zhao Y, Du
Y, Zhao S and Guo Z: Single-nucleotide polymorphisms of microRNA
processing machinery genes and risk of colorectal cancer. Onco
Targets Ther 8: 421–425, 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhao Y, Du Y, Zhao S and Guo Z:
Single-nucleotide polymorphisms of microRNA processing machinery
genes and risk of colorectal cancer. Onco Targets Ther. 8:421–5.
2015.PubMed/NCBI
|
|
18
|
Ye P, Li Z, Jiang H and Liu T: SNPs in
microRNA-binding sites in the ITGB1 and ITGB3 3′-UTR increase
colorectal cancer risk. Cell Biochem Biophys. 70:601–607. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cao Y, Zhang L, Ritprajak P, Tsushima F,
Youngnak-Piboonratanakit P, Kamimura Y, Hashiguchi M and Azuma M:
Immunoregulatory molecule B7-H1 (CD274) contributes to skin
carcinogenesis. Cancer Res. 71:4737–4741. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tsushima F, Tanaka K, Otsuki N, Youngnak
P, Iwai H, Omura K and Azuma M: Predominant expression of B7-H1 and
its immunoregulatory roles in oral squamous cell carcinoma. Oral
Oncol. 42:268–274. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lee SJ, Jang BC, Lee SW, Yang YI, Suh SI,
Park YM, Oh S, Shin JG, Yao S, Chen L and Choi IH: Interferon
regulatory factor-1 is prerequisite to the constitutive expression
and IFN-gamma-induced upregulation of B7-H1 (CD274). FEBS Lett.
580:755–762. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Blank C, Gajewski TF and Mackensen A:
Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T
cells as a mechanism of immune evasion: Implications for tumor
immunotherapy. Cancer Immunol Immunother. 54:307–314. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Keir ME, Butte MJ, Freeman GJ and Sharpe
AH: PD-1 and its ligands in tolerance and immunity. Annu Rev
Immunol. 26:677–704. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Youngnak-Piboonratanakit P, Tsushima F,
Otsuki N, Igarashi H, Machida U, Iwai H, Takahashi Y, Omura K,
Yokozeki H and Azuma M: The expression of B7-H1 on keratinocytes in
chronic inflammatory mucocutaneous disease and its regulatory role.
Immunol Lett. 94:215–222. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ryan BM, Robles AI and Harris CC: Genetic
variation in microRNA networks: The implications for cancer
research. Nat Rev Cancer. 10:389–402. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang J, Yu H, Zhang Y, Zhang X, Zheng G,
Gao Y, Wang C and Zhou L: A functional TNFAIP2 3′-UTR rs8126
genetic polymorphism contributes to risk of esophageal squamous
cell carcinoma. PLoS One. 9:e1093182014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cheng M, Yang L, Yang R, Yang X, Deng J,
Yu B, Huang D, Zhang S, Wang H, Qiu F, et al: A microRNA-135a/b
binding polymorphism in CD133 confers decreased risk and favorable
prognosis of lung cancer in Chinese by reducing CD133 expression.
Carcinogenesis. 34:2292–2299. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee SY, Choi JE, Jeon HS, Hong MJ, Choi
YY, Kang HG, Yoo SS, Lee EB, Jeong JY, Lee WK, et al: A genetic
variation in microRNA target site of KRT81 gene is associated with
survival in early-stage non-small-cell lung cancer. Ann Oncol.
26:1142–1148. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Takamizawa J, Konishi H, Yanagisawa K,
Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y,
et al: Reduced expression of the let-7 microRNAs in human lung
cancers in association with shortened postoperative survival.
Cancer Res. 64:3753–3756. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yu Z, Li Z, Jolicoeur N, Zhang L, Fortin
Y, Wang E, Wu M and Shen SH: Aberrant allele frequencies of the
SNPs located in microRNA target sites are potentially associated
with human cancers. Nucleic Acids Res. 35:4535–4541. 2007.
View Article : Google Scholar : PubMed/NCBI
|
